This article considers the challenges and potential benefits of combining the two. The nasal delivery of biologics offers considerable potential for both local and systemic action and for direct access to the brain and CNS to address currently unmet therapeutic need. The unique features of biologics are discussed with reference to the associated difficulties of nasal delivery and the benefits of partnership with experts such as Aptar Pharma is highlighted. Work on the development of vaccines and prophylactics for COVID-19 illustrates what is achievable.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Understanding PBPK Modeling in OINDPs: Insights from Will Ganley
Publications, Pharmaceutical, Product Solutions, Market Insights
Advancing Nose to Brain Drug Delivery: Intranasal Administration of Insulin
Publications, Pharmaceutical, Market Insights, Product Solutions, Innovation & Insights, Device Innovations
Cyclosporine – A Micellar Nasal Spray: A Promising Antiviral Solution Against S...
Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions
Advancing OINDP Clinical Trials with Speed and Efficiency: Strategies for Success
Publications, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions
